BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 233 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2019. The put-call ratio across all filers is 1.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $348,000 | +6860.0% | 5,280 | +4881.1% | 0.01% | – |
| Q2 2022 | $5,000 | -97.6% | 106 | -96.8% | 0.00% | -100.0% |
| Q1 2022 | $212,000 | +161.7% | 3,313 | +321.5% | 0.01% | +133.3% |
| Q3 2021 | $81,000 | +72.3% | 786 | +55.3% | 0.00% | -40.0% |
| Q3 2020 | $47,000 | +683.3% | 506 | +612.7% | 0.01% | +400.0% |
| Q2 2020 | $6,000 | -76.0% | 71 | -83.2% | 0.00% | -90.9% |
| Q1 2020 | $25,000 | -75.5% | 423 | -69.4% | 0.01% | -62.1% |
| Q3 2019 | $102,000 | +200.0% | 1,384 | +217.4% | 0.03% | +141.7% |
| Q3 2018 | $34,000 | – | 436 | +43500.0% | 0.01% | – |
| Q4 2017 | $0 | -100.0% | 1 | -99.7% | 0.00% | -100.0% |
| Q3 2017 | $26,000 | -65.3% | 367 | -80.5% | 0.02% | -81.6% |
| Q1 2017 | $75,000 | – | 1,886 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 581,768 | $25,487,256 | 9.57% |
| Casdin Capital, LLC | 1,477,800 | $64,742,418 | 5.02% |
| Nextech Invest Ltd. | 188,228 | $8,246,269 | 3.28% |
| DAFNA Capital Management LLC | 261,235 | $11,444,705 | 3.22% |
| Rock Springs Capital Management LP | 1,891,510 | $82,867,053 | 1.99% |
| HealthCor Management, L.P. | 30,000 | $1,314,300 | 1.20% |
| EFG Asset Management (North America) Corp. | 110,853 | $4,766,679 | 1.07% |
| Novo Holdings A/S | 370,000 | $16,209,700 | 1.01% |
| SECTORAL ASSET MANAGEMENT INC | 115,900 | $5,077,579 | 0.98% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 305,709 | $13,393,111 | 0.83% |